• Bavarian Nordic posted Q2 revenue up 23% to DKK 2.03 billion; EBITDA climbed to DKK 925 million, lifting margin 12 percentage points to 45%.
• H1 revenue rose 3% to DKK 3.09 billion; EBITDA reached DKK 1.09 billion, widening margin 3 percentage points to 35%.
• Travel Health revenue jumped 45% to DKK 1.02 billion on strong RabAvert/Rabipur sales; Public Preparedness revenue increased 6% to DKK 975 million.
• Upgraded 2026 guidance targets revenue of about DKK 5.7 billion; EBITDA margin seen at about 30%, up from about 28%.
• US exercised options worth USD 97 million for freeze-dried JYNNEOS; planned a new 2026 share buy-back of up to DKK 750 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bavarian Nordic A/S published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608210151OMX_____CNEWS_EN_GNW1001258636_en) on August 21, 2026, and is solely responsible for the information contained therein.